Department of Otolaryngology-Head and Neck Surgery, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Adult Cystic Fibrosis Centre, St Michael's Hospital, Toronto, Ontario, Canada.
Otolaryngol Head Neck Surg. 2020 Apr;162(4):572-580. doi: 10.1177/0194599820904956. Epub 2020 Feb 25.
To examine the effects of the extent of endoscopic sinus surgery (ESS) on pulmonary health, including the pulmonary exacerbations and lung function in patients with cystic fibrosis (CF).
Retrospective cohort study.
Tertiary health care center.
A retrospective review of patients with CF who underwent ESS at St. Michael's Hospital between 1999 and 2016 was performed. Two groups of patients were identified based on the surgical extent: (1) complete (maxillary antrostomy, complete ethmoidectomy, sphenoidotomy, and frontal sinusotomy) and (2) limited (any ESS that involved less than complete). Primary outcomes included the number of pulmonary exacerbations (the use of oral or intravenous [IV] antibiotics), number of hospital admissions and hospital days during a 2-year pre- and postoperative period, and pulmonary function outcomes during a 1-year pre- and postoperative period.
There were 70 procedures (30 complete and 40 limited) among 57 patients. Baseline characteristics were similar between the groups. Complete ESS group had a significant reduction in the oral antibiotic use compared to the limited ESS group (median, -1.0 [interquartile range (IQR), -2 to 0] in complete vs 0 [IQR, -1 to 1] in limited, = .028). There was no difference in the use of IV antibiotics, number and duration of admissions, or rate of lung function change between the 2 groups.
Complete ESS may reduce mild forms of pulmonary exacerbations as shown in the decreased use of oral antibiotics. Overall, ESS does not significantly modify pulmonary outcomes in patients with CF.
研究内镜鼻窦手术(ESS)范围对囊性纤维化(CF)患者肺部健康的影响,包括肺部恶化和肺功能。
回顾性队列研究。
三级保健中心。
对 1999 年至 2016 年期间在圣迈克尔医院接受 ESS 的 CF 患者进行了回顾性审查。根据手术范围确定了两组患者:(1)完全(上颌窦切开术、完整的筛窦切除术、蝶窦切开术和额窦切开术)和(2)有限(任何涉及少于完全的 ESS)。主要结果包括肺部恶化次数(口服或静脉[IV]抗生素的使用)、2 年术前和术后期间的住院次数和住院天数以及 1 年术前和术后期间的肺功能结果。
57 名患者中有 70 例(30 例完全和 40 例有限)进行了手术。两组患者的基线特征相似。与有限 ESS 组相比,完全 ESS 组口服抗生素的使用明显减少(中位数,-1.0[四分位距(IQR),-2 至 0]与完全 ESS 组的 0[IQR,-1 至 1], =.028)。两组之间 IV 抗生素的使用、住院次数和持续时间或肺功能变化率没有差异。
完全 ESS 可能会减少轻度肺部恶化,表现为口服抗生素的使用减少。总体而言,ESS 不会显着改变 CF 患者的肺部结局。